Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Prognostic Impacts and Clinical Utility of the Characteristics of New-onset Atrial Fibrillation Complicating Acute Myocardial Infarction in China

NCT05511649 is registered in ClinicalTrials.gov with Shanghai 10th People's Hospital as lead sponsor.

NCT NCT05511649
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05511649 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Prognostic Impacts and Clinical Utility of the Characteristics of New-onset Atrial Fibrillation Complicating Acute Myocardial Infarction in China
Lead sponsor
Shanghai 10th People's Hospital
Phase
Observational
Overall status
Completed
Start date
March 1, 2023
Completion date
September 23, 2023
Enrollment
832 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

acute myocardial infarction, new onset atrial fibrillation